Symbols

HELX

·CBOE

--(--)

Key Stats

Assets Under Management

22.25MUSD

Fund Flows (1Y)

4.35MUSD

Dividend Yield

Discount/Premium to NAV

0.03%

Shares Outstanding

600.00K

Expense Ratio

0.50%

About Franklin Genomic Advancements ETF

Issuer

Franklin Advisers, Inc.

Brand

Franklin

Home Page

https://www.franklintempleton.com/investor/investments-and-solutions/investment-options/etfs/overview/29097/franklin-genomic-advancements-etf

Inception Date

Feb 25, 2020

Structure

Open-Ended Fund

Index Tracked

Management Style

Active

Dividend Treatment

Distributes

Distribution Tax Treatment

Qualified dividends

Income Tax Type

Capital Gains

Max ST Capital Gains Rate

39.60%

Max LT Capital Gains Rate

20.00%

Primary Advisor

Franklin Advisers, Inc.

Distributor

Franklin Distributors LLC

HELX invests in global companies benefitting from the advancements of genomic-based research techniques and technologies that are designed to extend or enhance the quality of life. The fund advisor uses fundamental research to identify and select stocks they feel best positioned to capitalize on such genomic advancements. Companies may include those that research, develop, produce or manufacture bionic devices, molecular medicine, pharmaceuticals and agricultural applications. HELX is one of the first three thematic funds to launch from Franklin Templeton.

Classification

Asset Class

Equity

	1-Month	3-Month	YTD	1-Year	3-Year	5-Year
Price Performance	-2.45%	+18.89%	+26.75%	+27.50%	+21.58%	-18.23%
NAV Total Return	+3.31%	+18.50%	+26.46%	+25.85%	+20.37%	-19.70%

No data is currently available

Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.

Learn More in ETF Compare

Holdings Analysis

Sector

Healthcare

97.36%

Basic Materials

1.90%

Technology

0.73%

Asset

Region

91.71%

4.58%

3.71%

Investment Style

Mega

Large

Medium

Multi

Small

Value

Blend

Growth

Multi-Cap Growth

Comprises companies of multiple sizes that have high growth potential. These ETFs focus on firms across different market caps with promising growth prospects.

See more ETFs with the same investment style